Institute of Pharmacy and Food Chemistry, Julius-Maximilians-University Wuerzburg, Am Hubland, D-97074 Wuerzburg, Germany.
J Chem Inf Model. 2010 Apr 26;50(4):604-14. doi: 10.1021/ci900403s.
HIV-1 integrase (IN) is a validated target of anti-AIDS research. The classical approach of designing active-site directed ligands has largely been exploited. A promising alternative strategy to inactivate the enzyme is to prevent the formation of IN dimers. The rational design of dimerization inhibitors, however, is hampered by the lack of relevant structural data about the targeted monomeric form. Therefore, we performed molecular dynamics simulations and subsequent analyses to gain insight into the structural features of the IN catalytic-core-domain dimerization interface. As a result, the formation of a groove and a cavity along the dimerization interface of the IN monomer could be revealed. Both were shown to be suited for accommodating an inhibitory peptide. The results form a valuable basis for the design of ligands targeting the dimerization interface and, thus, of a whole new class of HIV-1 integrase inhibitors.
HIV-1 整合酶(IN)是抗艾滋病研究的一个经过验证的靶点。设计针对活性位点的配体的经典方法已经得到了广泛的应用。另一种有前途的使酶失活的策略是阻止 IN 二聚体的形成。然而,由于缺乏关于靶向单体形式的相关结构数据,二聚化抑制剂的合理设计受到了阻碍。因此,我们进行了分子动力学模拟和后续分析,以深入了解 IN 催化核心结构域二聚化界面的结构特征。结果表明,在 IN 单体的二聚化界面上形成了一个沟槽和一个空腔。这两个结构都适合容纳一个抑制肽。这些结果为设计针对二聚化界面的配体提供了有价值的基础,从而为一类全新的 HIV-1 整合酶抑制剂的设计提供了基础。